nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—migraine—Acetylsalicylic acid—coronary artery disease	0.203	0.508	CpDpCtD
Cyclobenzaprine—osteoarthritis—Acetylsalicylic acid—coronary artery disease	0.196	0.492	CpDpCtD
Cyclobenzaprine—HTR2A—coronary artery disease	0.156	1	CbGaD
Cyclobenzaprine—CYP1A2—Gemfibrozil—coronary artery disease	0.0254	0.0957	CbGbCtD
Cyclobenzaprine—CYP1A2—Clopidogrel—coronary artery disease	0.0221	0.083	CbGbCtD
Cyclobenzaprine—CYP3A4—Ticagrelor—coronary artery disease	0.0187	0.0704	CbGbCtD
Cyclobenzaprine—CYP3A4—Fenofibrate—coronary artery disease	0.0167	0.0627	CbGbCtD
Cyclobenzaprine—CYP2D6—Niacin—coronary artery disease	0.0138	0.0518	CbGbCtD
Cyclobenzaprine—CYP3A4—Gemfibrozil—coronary artery disease	0.0133	0.0502	CbGbCtD
Cyclobenzaprine—CYP2D6—Timolol—coronary artery disease	0.0128	0.0482	CbGbCtD
Cyclobenzaprine—CYP3A4—Clopidogrel—coronary artery disease	0.0116	0.0435	CbGbCtD
Cyclobenzaprine—CYP2D6—Captopril—coronary artery disease	0.0113	0.0424	CbGbCtD
Cyclobenzaprine—CYP2D6—Simvastatin—coronary artery disease	0.0109	0.041	CbGbCtD
Cyclobenzaprine—CYP1A2—Losartan—coronary artery disease	0.0108	0.0405	CbGbCtD
Cyclobenzaprine—CYP3A4—Eplerenone—coronary artery disease	0.0107	0.0404	CbGbCtD
Cyclobenzaprine—CYP2D6—Pravastatin—coronary artery disease	0.0107	0.0401	CbGbCtD
Cyclobenzaprine—CYP2D6—Lovastatin—coronary artery disease	0.0107	0.0401	CbGbCtD
Cyclobenzaprine—CYP2D6—Atorvastatin—coronary artery disease	0.0097	0.0365	CbGbCtD
Cyclobenzaprine—CYP3A4—Enalapril—coronary artery disease	0.00957	0.036	CbGbCtD
Cyclobenzaprine—CYP3A4—Ezetimibe—coronary artery disease	0.00745	0.028	CbGbCtD
Cyclobenzaprine—CYP3A4—Rosuvastatin—coronary artery disease	0.00745	0.028	CbGbCtD
Cyclobenzaprine—CYP3A4—Simvastatin—coronary artery disease	0.00692	0.026	CbGbCtD
Cyclobenzaprine—CYP3A4—Pravastatin—coronary artery disease	0.00677	0.0255	CbGbCtD
Cyclobenzaprine—CYP3A4—Lovastatin—coronary artery disease	0.00677	0.0255	CbGbCtD
Cyclobenzaprine—CYP3A4—Atorvastatin—coronary artery disease	0.00617	0.0232	CbGbCtD
Cyclobenzaprine—CYP3A4—Losartan—coronary artery disease	0.00564	0.0212	CbGbCtD
Cyclobenzaprine—HTR2A—arteriole—coronary artery disease	0.00305	0.207	CbGeAlD
Cyclobenzaprine—HTR2A—pulmonary artery—coronary artery disease	0.00199	0.136	CbGeAlD
Cyclobenzaprine—HTR2A—sympathetic nervous system—coronary artery disease	0.00194	0.132	CbGeAlD
Cyclobenzaprine—HTR2A—vagus nerve—coronary artery disease	0.00188	0.128	CbGeAlD
Cyclobenzaprine—HTR2A—vein—coronary artery disease	0.00182	0.123	CbGeAlD
Cyclobenzaprine—HTR2A—autonomic nervous system—coronary artery disease	0.0013	0.0887	CbGeAlD
Cyclobenzaprine—Phenindione—VKORC1—coronary artery disease	0.000901	0.296	CrCbGaD
Cyclobenzaprine—HTR2A—artery—coronary artery disease	0.00074	0.0503	CbGeAlD
Cyclobenzaprine—HTR2A—endothelium—coronary artery disease	0.000625	0.0425	CbGeAlD
Cyclobenzaprine—Olopatadine—S100B—coronary artery disease	0.000445	0.146	CrCbGaD
Cyclobenzaprine—HTR2A—heart—coronary artery disease	0.000272	0.0185	CbGeAlD
Cyclobenzaprine—CYP1A2—blood—coronary artery disease	0.00026	0.0177	CbGeAlD
Cyclobenzaprine—HTR2A—cardiovascular system—coronary artery disease	0.000257	0.0175	CbGeAlD
Cyclobenzaprine—Carbamazepine—RALBP1—coronary artery disease	0.000248	0.0816	CrCbGaD
Cyclobenzaprine—Tamoxifen—SULT1A1—coronary artery disease	0.000243	0.0798	CrCbGaD
Cyclobenzaprine—HTR2A—blood—coronary artery disease	0.000203	0.0138	CbGeAlD
Cyclobenzaprine—CYP3A4—blood—coronary artery disease	0.000188	0.0128	CbGeAlD
Cyclobenzaprine—CYP2D6—blood—coronary artery disease	0.000185	0.0126	CbGeAlD
Cyclobenzaprine—Doxepin—HRH2—coronary artery disease	0.000159	0.0525	CrCbGaD
Cyclobenzaprine—Amitriptyline—HRH2—coronary artery disease	0.000123	0.0406	CrCbGaD
Cyclobenzaprine—Tamoxifen—ESR2—coronary artery disease	6.82e-05	0.0225	CrCbGaD
Cyclobenzaprine—Imipramine—SLC22A3—coronary artery disease	6.65e-05	0.0219	CrCbGaD
Cyclobenzaprine—Amitriptyline—OPRD1—coronary artery disease	6.51e-05	0.0214	CrCbGaD
Cyclobenzaprine—Feeling abnormal—Perindopril—coronary artery disease	5.41e-05	0.000409	CcSEcCtD
Cyclobenzaprine—Headache—Lovastatin—coronary artery disease	5.4e-05	0.000408	CcSEcCtD
Cyclobenzaprine—Pruritus—Valsartan—coronary artery disease	5.39e-05	0.000407	CcSEcCtD
Cyclobenzaprine—Dry mouth—Ramipril—coronary artery disease	5.39e-05	0.000407	CcSEcCtD
Cyclobenzaprine—Myalgia—Timolol—coronary artery disease	5.39e-05	0.000407	CcSEcCtD
Cyclobenzaprine—Chest pain—Timolol—coronary artery disease	5.39e-05	0.000407	CcSEcCtD
Cyclobenzaprine—Vomiting—Ezetimibe—coronary artery disease	5.38e-05	0.000406	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Pravastatin—coronary artery disease	5.37e-05	0.000406	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Perindopril—coronary artery disease	5.37e-05	0.000406	CcSEcCtD
Cyclobenzaprine—Anxiety—Timolol—coronary artery disease	5.37e-05	0.000406	CcSEcCtD
Cyclobenzaprine—Angioedema—Lisinopril—coronary artery disease	5.36e-05	0.000405	CcSEcCtD
Cyclobenzaprine—Pruritus—Olmesartan—coronary artery disease	5.36e-05	0.000405	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Losartan—coronary artery disease	5.35e-05	0.000405	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Captopril—coronary artery disease	5.35e-05	0.000404	CcSEcCtD
Cyclobenzaprine—Dizziness—Simvastatin—coronary artery disease	5.33e-05	0.000403	CcSEcCtD
Cyclobenzaprine—Rash—Ezetimibe—coronary artery disease	5.33e-05	0.000403	CcSEcCtD
Cyclobenzaprine—Dermatitis—Ezetimibe—coronary artery disease	5.33e-05	0.000403	CcSEcCtD
Cyclobenzaprine—Confusional state—Ramipril—coronary artery disease	5.32e-05	0.000402	CcSEcCtD
Cyclobenzaprine—Discomfort—Timolol—coronary artery disease	5.32e-05	0.000402	CcSEcCtD
Cyclobenzaprine—Asthenia—Niacin—coronary artery disease	5.31e-05	0.000402	CcSEcCtD
Cyclobenzaprine—Fatigue—Losartan—coronary artery disease	5.31e-05	0.000401	CcSEcCtD
Cyclobenzaprine—Headache—Ezetimibe—coronary artery disease	5.3e-05	0.0004	CcSEcCtD
Cyclobenzaprine—Malaise—Lisinopril—coronary artery disease	5.29e-05	0.0004	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Ramipril—coronary artery disease	5.28e-05	0.000399	CcSEcCtD
Cyclobenzaprine—Oedema—Ramipril—coronary artery disease	5.28e-05	0.000399	CcSEcCtD
Cyclobenzaprine—Vertigo—Lisinopril—coronary artery disease	5.27e-05	0.000398	CcSEcCtD
Cyclobenzaprine—Dry mouth—Timolol—coronary artery disease	5.27e-05	0.000398	CcSEcCtD
Cyclobenzaprine—Constipation—Losartan—coronary artery disease	5.27e-05	0.000398	CcSEcCtD
Cyclobenzaprine—Syncope—Lisinopril—coronary artery disease	5.26e-05	0.000398	CcSEcCtD
Cyclobenzaprine—Vomiting—Eplerenone—coronary artery disease	5.26e-05	0.000398	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Furosemide—coronary artery disease	5.26e-05	0.000398	CcSEcCtD
Cyclobenzaprine—Leukopenia—Lisinopril—coronary artery disease	5.25e-05	0.000397	CcSEcCtD
Cyclobenzaprine—Nausea—Fenofibrate—coronary artery disease	5.24e-05	0.000396	CcSEcCtD
Cyclobenzaprine—Pruritus—Niacin—coronary artery disease	5.24e-05	0.000396	CcSEcCtD
Cyclobenzaprine—Asthenia—Pravastatin—coronary artery disease	5.23e-05	0.000395	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Furosemide—coronary artery disease	5.22e-05	0.000395	CcSEcCtD
Cyclobenzaprine—Rash—Eplerenone—coronary artery disease	5.22e-05	0.000394	CcSEcCtD
Cyclobenzaprine—Urticaria—Perindopril—coronary artery disease	5.22e-05	0.000394	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Trandolapril—coronary artery disease	5.22e-05	0.000394	CcSEcCtD
Cyclobenzaprine—Dermatitis—Eplerenone—coronary artery disease	5.21e-05	0.000394	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Valsartan—coronary artery disease	5.21e-05	0.000394	CcSEcCtD
Cyclobenzaprine—Confusional state—Timolol—coronary artery disease	5.21e-05	0.000393	CcSEcCtD
Cyclobenzaprine—Shock—Ramipril—coronary artery disease	5.2e-05	0.000393	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Enalapril—coronary artery disease	5.2e-05	0.000393	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Perindopril—coronary artery disease	5.19e-05	0.000392	CcSEcCtD
Cyclobenzaprine—Palpitations—Lisinopril—coronary artery disease	5.19e-05	0.000392	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Olmesartan—coronary artery disease	5.19e-05	0.000392	CcSEcCtD
Cyclobenzaprine—Headache—Eplerenone—coronary artery disease	5.18e-05	0.000392	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Ramipril—coronary artery disease	5.17e-05	0.000391	CcSEcCtD
Cyclobenzaprine—Oedema—Timolol—coronary artery disease	5.16e-05	0.00039	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Timolol—coronary artery disease	5.16e-05	0.00039	CcSEcCtD
Cyclobenzaprine—Pruritus—Pravastatin—coronary artery disease	5.16e-05	0.00039	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Lisinopril—coronary artery disease	5.16e-05	0.00039	CcSEcCtD
Cyclobenzaprine—Nausea—Clopidogrel—coronary artery disease	5.16e-05	0.00039	CcSEcCtD
Cyclobenzaprine—Tachycardia—Ramipril—coronary artery disease	5.15e-05	0.00039	CcSEcCtD
Cyclobenzaprine—Vomiting—Simvastatin—coronary artery disease	5.13e-05	0.000388	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Telmisartan—coronary artery disease	5.12e-05	0.000387	CcSEcCtD
Cyclobenzaprine—Nausea—Lovastatin—coronary artery disease	5.12e-05	0.000387	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Ramipril—coronary artery disease	5.11e-05	0.000386	CcSEcCtD
Cyclobenzaprine—Rash—Simvastatin—coronary artery disease	5.08e-05	0.000384	CcSEcCtD
Cyclobenzaprine—Dermatitis—Simvastatin—coronary artery disease	5.08e-05	0.000384	CcSEcCtD
Cyclobenzaprine—Asthenia—Trandolapril—coronary artery disease	5.08e-05	0.000384	CcSEcCtD
Cyclobenzaprine—Shock—Timolol—coronary artery disease	5.08e-05	0.000384	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Losartan—coronary artery disease	5.08e-05	0.000384	CcSEcCtD
Cyclobenzaprine—Urticaria—Furosemide—coronary artery disease	5.07e-05	0.000383	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Niacin—coronary artery disease	5.07e-05	0.000383	CcSEcCtD
Cyclobenzaprine—Asthenia—Enalapril—coronary artery disease	5.06e-05	0.000382	CcSEcCtD
Cyclobenzaprine—Headache—Simvastatin—coronary artery disease	5.05e-05	0.000382	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Furosemide—coronary artery disease	5.05e-05	0.000381	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Losartan—coronary artery disease	5.04e-05	0.000381	CcSEcCtD
Cyclobenzaprine—Dizziness—Valsartan—coronary artery disease	5.04e-05	0.000381	CcSEcCtD
Cyclobenzaprine—Anorexia—Ramipril—coronary artery disease	5.03e-05	0.00038	CcSEcCtD
Cyclobenzaprine—Nausea—Ezetimibe—coronary artery disease	5.02e-05	0.00038	CcSEcCtD
Cyclobenzaprine—Dizziness—Olmesartan—coronary artery disease	5.01e-05	0.000379	CcSEcCtD
Cyclobenzaprine—Pruritus—Trandolapril—coronary artery disease	5.01e-05	0.000379	CcSEcCtD
Cyclobenzaprine—Chest pain—Lisinopril—coronary artery disease	5e-05	0.000378	CcSEcCtD
Cyclobenzaprine—Myalgia—Lisinopril—coronary artery disease	5e-05	0.000378	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Timolol—coronary artery disease	4.99e-05	0.000377	CcSEcCtD
Cyclobenzaprine—Asthenia—Telmisartan—coronary artery disease	4.99e-05	0.000377	CcSEcCtD
Cyclobenzaprine—Pruritus—Enalapril—coronary artery disease	4.99e-05	0.000377	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Pravastatin—coronary artery disease	4.99e-05	0.000377	CcSEcCtD
Cyclobenzaprine—Anxiety—Lisinopril—coronary artery disease	4.98e-05	0.000376	CcSEcCtD
Cyclobenzaprine—Discomfort—Lisinopril—coronary artery disease	4.94e-05	0.000373	CcSEcCtD
Cyclobenzaprine—Hypotension—Ramipril—coronary artery disease	4.93e-05	0.000373	CcSEcCtD
Cyclobenzaprine—Anorexia—Timolol—coronary artery disease	4.92e-05	0.000372	CcSEcCtD
Cyclobenzaprine—Pruritus—Telmisartan—coronary artery disease	4.92e-05	0.000372	CcSEcCtD
Cyclobenzaprine—Nausea—Eplerenone—coronary artery disease	4.92e-05	0.000372	CcSEcCtD
Cyclobenzaprine—Dizziness—Niacin—coronary artery disease	4.9e-05	0.00037	CcSEcCtD
Cyclobenzaprine—Urticaria—Losartan—coronary artery disease	4.89e-05	0.00037	CcSEcCtD
Cyclobenzaprine—Dry mouth—Lisinopril—coronary artery disease	4.89e-05	0.000369	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Losartan—coronary artery disease	4.87e-05	0.000368	CcSEcCtD
Cyclobenzaprine—Asthenia—Captopril—coronary artery disease	4.85e-05	0.000367	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Trandolapril—coronary artery disease	4.84e-05	0.000366	CcSEcCtD
Cyclobenzaprine—Vomiting—Valsartan—coronary artery disease	4.84e-05	0.000366	CcSEcCtD
Cyclobenzaprine—Confusional state—Lisinopril—coronary artery disease	4.83e-05	0.000365	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Enalapril—coronary artery disease	4.82e-05	0.000365	CcSEcCtD
Cyclobenzaprine—Hypotension—Timolol—coronary artery disease	4.82e-05	0.000365	CcSEcCtD
Cyclobenzaprine—Dizziness—Pravastatin—coronary artery disease	4.82e-05	0.000364	CcSEcCtD
Cyclobenzaprine—Vomiting—Olmesartan—coronary artery disease	4.82e-05	0.000364	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.81e-05	0.000364	CcSEcCtD
Cyclobenzaprine—Rash—Valsartan—coronary artery disease	4.8e-05	0.000363	CcSEcCtD
Cyclobenzaprine—Dermatitis—Valsartan—coronary artery disease	4.8e-05	0.000363	CcSEcCtD
Cyclobenzaprine—Nausea—Simvastatin—coronary artery disease	4.79e-05	0.000362	CcSEcCtD
Cyclobenzaprine—Oedema—Lisinopril—coronary artery disease	4.79e-05	0.000362	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Lisinopril—coronary artery disease	4.79e-05	0.000362	CcSEcCtD
Cyclobenzaprine—Pruritus—Captopril—coronary artery disease	4.78e-05	0.000362	CcSEcCtD
Cyclobenzaprine—Rash—Olmesartan—coronary artery disease	4.78e-05	0.000361	CcSEcCtD
Cyclobenzaprine—Insomnia—Ramipril—coronary artery disease	4.78e-05	0.000361	CcSEcCtD
Cyclobenzaprine—Dermatitis—Olmesartan—coronary artery disease	4.77e-05	0.000361	CcSEcCtD
Cyclobenzaprine—Headache—Valsartan—coronary artery disease	4.77e-05	0.000361	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Telmisartan—coronary artery disease	4.76e-05	0.00036	CcSEcCtD
Cyclobenzaprine—Headache—Olmesartan—coronary artery disease	4.75e-05	0.000359	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Ramipril—coronary artery disease	4.74e-05	0.000358	CcSEcCtD
Cyclobenzaprine—Shock—Lisinopril—coronary artery disease	4.71e-05	0.000356	CcSEcCtD
Cyclobenzaprine—Asthenia—Perindopril—coronary artery disease	4.71e-05	0.000356	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Ramipril—coronary artery disease	4.71e-05	0.000356	CcSEcCtD
Cyclobenzaprine—Vomiting—Niacin—coronary artery disease	4.71e-05	0.000356	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Timolol—coronary artery disease	4.7e-05	0.000356	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Furosemide—coronary artery disease	4.7e-05	0.000355	CcSEcCtD
Cyclobenzaprine—Somnolence—Ramipril—coronary artery disease	4.69e-05	0.000355	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Lisinopril—coronary artery disease	4.69e-05	0.000354	CcSEcCtD
Cyclobenzaprine—Dizziness—Trandolapril—coronary artery disease	4.68e-05	0.000354	CcSEcCtD
Cyclobenzaprine—Tachycardia—Lisinopril—coronary artery disease	4.67e-05	0.000353	CcSEcCtD
Cyclobenzaprine—Insomnia—Timolol—coronary artery disease	4.67e-05	0.000353	CcSEcCtD
Cyclobenzaprine—Rash—Niacin—coronary artery disease	4.67e-05	0.000353	CcSEcCtD
Cyclobenzaprine—Dermatitis—Niacin—coronary artery disease	4.66e-05	0.000353	CcSEcCtD
Cyclobenzaprine—Dizziness—Enalapril—coronary artery disease	4.66e-05	0.000352	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Ramipril—coronary artery disease	4.65e-05	0.000351	CcSEcCtD
Cyclobenzaprine—Pruritus—Perindopril—coronary artery disease	4.65e-05	0.000351	CcSEcCtD
Cyclobenzaprine—Headache—Niacin—coronary artery disease	4.64e-05	0.000351	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Timolol—coronary artery disease	4.64e-05	0.00035	CcSEcCtD
Cyclobenzaprine—Vomiting—Pravastatin—coronary artery disease	4.64e-05	0.00035	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Lisinopril—coronary artery disease	4.63e-05	0.00035	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Captopril—coronary artery disease	4.63e-05	0.00035	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Timolol—coronary artery disease	4.6e-05	0.000348	CcSEcCtD
Cyclobenzaprine—Dizziness—Telmisartan—coronary artery disease	4.6e-05	0.000348	CcSEcCtD
Cyclobenzaprine—Rash—Pravastatin—coronary artery disease	4.6e-05	0.000347	CcSEcCtD
Cyclobenzaprine—Dermatitis—Pravastatin—coronary artery disease	4.59e-05	0.000347	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Ramipril—coronary artery disease	4.59e-05	0.000347	CcSEcCtD
Cyclobenzaprine—Somnolence—Timolol—coronary artery disease	4.59e-05	0.000347	CcSEcCtD
Cyclobenzaprine—Asthenia—Furosemide—coronary artery disease	4.58e-05	0.000346	CcSEcCtD
Cyclobenzaprine—Headache—Pravastatin—coronary artery disease	4.57e-05	0.000345	CcSEcCtD
Cyclobenzaprine—Anorexia—Lisinopril—coronary artery disease	4.57e-05	0.000345	CcSEcCtD
Cyclobenzaprine—Fatigue—Ramipril—coronary artery disease	4.55e-05	0.000344	CcSEcCtD
Cyclobenzaprine—Carbamazepine—CYP2C19—coronary artery disease	4.55e-05	0.015	CrCbGaD
Cyclobenzaprine—Dyspepsia—Timolol—coronary artery disease	4.54e-05	0.000343	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Losartan—coronary artery disease	4.54e-05	0.000343	CcSEcCtD
Cyclobenzaprine—Nausea—Valsartan—coronary artery disease	4.52e-05	0.000342	CcSEcCtD
Cyclobenzaprine—Pruritus—Furosemide—coronary artery disease	4.52e-05	0.000341	CcSEcCtD
Cyclobenzaprine—Constipation—Ramipril—coronary artery disease	4.52e-05	0.000341	CcSEcCtD
Cyclobenzaprine—Nausea—Olmesartan—coronary artery disease	4.5e-05	0.00034	CcSEcCtD
Cyclobenzaprine—Vomiting—Trandolapril—coronary artery disease	4.5e-05	0.00034	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Perindopril—coronary artery disease	4.49e-05	0.00034	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Timolol—coronary artery disease	4.49e-05	0.000339	CcSEcCtD
Cyclobenzaprine—Cyproheptadine—HTR2A—coronary artery disease	4.49e-05	0.0148	CrCbGaD
Cyclobenzaprine—Vomiting—Enalapril—coronary artery disease	4.48e-05	0.000339	CcSEcCtD
Cyclobenzaprine—Hypotension—Lisinopril—coronary artery disease	4.48e-05	0.000338	CcSEcCtD
Cyclobenzaprine—Dizziness—Captopril—coronary artery disease	4.47e-05	0.000338	CcSEcCtD
Cyclobenzaprine—Rash—Trandolapril—coronary artery disease	4.46e-05	0.000337	CcSEcCtD
Cyclobenzaprine—Dermatitis—Trandolapril—coronary artery disease	4.46e-05	0.000337	CcSEcCtD
Cyclobenzaprine—Fatigue—Timolol—coronary artery disease	4.45e-05	0.000336	CcSEcCtD
Cyclobenzaprine—Rash—Enalapril—coronary artery disease	4.45e-05	0.000336	CcSEcCtD
Cyclobenzaprine—Dermatitis—Enalapril—coronary artery disease	4.44e-05	0.000336	CcSEcCtD
Cyclobenzaprine—Headache—Trandolapril—coronary artery disease	4.44e-05	0.000335	CcSEcCtD
Cyclobenzaprine—Vomiting—Telmisartan—coronary artery disease	4.42e-05	0.000334	CcSEcCtD
Cyclobenzaprine—Asthenia—Losartan—coronary artery disease	4.42e-05	0.000334	CcSEcCtD
Cyclobenzaprine—Headache—Enalapril—coronary artery disease	4.42e-05	0.000334	CcSEcCtD
Cyclobenzaprine—Nausea—Niacin—coronary artery disease	4.4e-05	0.000332	CcSEcCtD
Cyclobenzaprine—Rash—Telmisartan—coronary artery disease	4.39e-05	0.000331	CcSEcCtD
Cyclobenzaprine—Dermatitis—Telmisartan—coronary artery disease	4.38e-05	0.000331	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Furosemide—coronary artery disease	4.37e-05	0.00033	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.36e-05	0.00033	CcSEcCtD
Cyclobenzaprine—Pruritus—Losartan—coronary artery disease	4.36e-05	0.000329	CcSEcCtD
Cyclobenzaprine—Headache—Telmisartan—coronary artery disease	4.36e-05	0.000329	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Ramipril—coronary artery disease	4.35e-05	0.000329	CcSEcCtD
Cyclobenzaprine—Dizziness—Perindopril—coronary artery disease	4.34e-05	0.000328	CcSEcCtD
Cyclobenzaprine—Insomnia—Lisinopril—coronary artery disease	4.33e-05	0.000327	CcSEcCtD
Cyclobenzaprine—Nausea—Pravastatin—coronary artery disease	4.33e-05	0.000327	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Ramipril—coronary artery disease	4.32e-05	0.000326	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Lisinopril—coronary artery disease	4.3e-05	0.000325	CcSEcCtD
Cyclobenzaprine—Vomiting—Captopril—coronary artery disease	4.3e-05	0.000325	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Lisinopril—coronary artery disease	4.27e-05	0.000323	CcSEcCtD
Cyclobenzaprine—Rash—Captopril—coronary artery disease	4.26e-05	0.000322	CcSEcCtD
Cyclobenzaprine—Dermatitis—Captopril—coronary artery disease	4.26e-05	0.000322	CcSEcCtD
Cyclobenzaprine—Somnolence—Lisinopril—coronary artery disease	4.26e-05	0.000322	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Timolol—coronary artery disease	4.25e-05	0.000322	CcSEcCtD
Cyclobenzaprine—Headache—Captopril—coronary artery disease	4.24e-05	0.00032	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Timolol—coronary artery disease	4.22e-05	0.000319	CcSEcCtD
Cyclobenzaprine—Dizziness—Furosemide—coronary artery disease	4.22e-05	0.000319	CcSEcCtD
Cyclobenzaprine—Imipramine—HTR7—coronary artery disease	4.22e-05	0.0139	CrCbGaD
Cyclobenzaprine—Dyspepsia—Lisinopril—coronary artery disease	4.22e-05	0.000319	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Losartan—coronary artery disease	4.21e-05	0.000318	CcSEcCtD
Cyclobenzaprine—Nausea—Trandolapril—coronary artery disease	4.21e-05	0.000318	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ESR1—coronary artery disease	4.2e-05	0.0138	CrCbGaD
Cyclobenzaprine—Urticaria—Ramipril—coronary artery disease	4.2e-05	0.000317	CcSEcCtD
Cyclobenzaprine—Amitriptyline—HTR7—coronary artery disease	4.19e-05	0.0138	CrCbGaD
Cyclobenzaprine—Nausea—Enalapril—coronary artery disease	4.19e-05	0.000317	CcSEcCtD
Cyclobenzaprine—Vomiting—Perindopril—coronary artery disease	4.17e-05	0.000316	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Ramipril—coronary artery disease	4.17e-05	0.000316	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Lisinopril—coronary artery disease	4.16e-05	0.000315	CcSEcCtD
Cyclobenzaprine—Rash—Perindopril—coronary artery disease	4.14e-05	0.000313	CcSEcCtD
Cyclobenzaprine—Dermatitis—Perindopril—coronary artery disease	4.14e-05	0.000313	CcSEcCtD
Cyclobenzaprine—Nausea—Telmisartan—coronary artery disease	4.13e-05	0.000312	CcSEcCtD
Cyclobenzaprine—Fatigue—Lisinopril—coronary artery disease	4.13e-05	0.000312	CcSEcCtD
Cyclobenzaprine—Headache—Perindopril—coronary artery disease	4.11e-05	0.000311	CcSEcCtD
Cyclobenzaprine—Urticaria—Timolol—coronary artery disease	4.1e-05	0.00031	CcSEcCtD
Cyclobenzaprine—Constipation—Lisinopril—coronary artery disease	4.1e-05	0.00031	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Timolol—coronary artery disease	4.08e-05	0.000308	CcSEcCtD
Cyclobenzaprine—Dizziness—Losartan—coronary artery disease	4.07e-05	0.000308	CcSEcCtD
Cyclobenzaprine—Vomiting—Furosemide—coronary artery disease	4.06e-05	0.000307	CcSEcCtD
Cyclobenzaprine—Rash—Furosemide—coronary artery disease	4.02e-05	0.000304	CcSEcCtD
Cyclobenzaprine—Dermatitis—Furosemide—coronary artery disease	4.02e-05	0.000304	CcSEcCtD
Cyclobenzaprine—Nausea—Captopril—coronary artery disease	4.02e-05	0.000304	CcSEcCtD
Cyclobenzaprine—Headache—Furosemide—coronary artery disease	4e-05	0.000302	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Lisinopril—coronary artery disease	3.95e-05	0.000298	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Lisinopril—coronary artery disease	3.92e-05	0.000296	CcSEcCtD
Cyclobenzaprine—Vomiting—Losartan—coronary artery disease	3.92e-05	0.000296	CcSEcCtD
Cyclobenzaprine—Nausea—Perindopril—coronary artery disease	3.9e-05	0.000295	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Ramipril—coronary artery disease	3.89e-05	0.000294	CcSEcCtD
Cyclobenzaprine—Rash—Losartan—coronary artery disease	3.88e-05	0.000294	CcSEcCtD
Cyclobenzaprine—Dermatitis—Losartan—coronary artery disease	3.88e-05	0.000293	CcSEcCtD
Cyclobenzaprine—Headache—Losartan—coronary artery disease	3.86e-05	0.000292	CcSEcCtD
Cyclobenzaprine—Urticaria—Lisinopril—coronary artery disease	3.8e-05	0.000288	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Timolol—coronary artery disease	3.8e-05	0.000287	CcSEcCtD
Cyclobenzaprine—Nausea—Furosemide—coronary artery disease	3.79e-05	0.000287	CcSEcCtD
Cyclobenzaprine—Asthenia—Ramipril—coronary artery disease	3.79e-05	0.000286	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Lisinopril—coronary artery disease	3.79e-05	0.000286	CcSEcCtD
Cyclobenzaprine—Nortriptyline—CYP2C19—coronary artery disease	3.75e-05	0.0123	CrCbGaD
Cyclobenzaprine—Pruritus—Ramipril—coronary artery disease	3.74e-05	0.000282	CcSEcCtD
Cyclobenzaprine—Asthenia—Timolol—coronary artery disease	3.7e-05	0.00028	CcSEcCtD
Cyclobenzaprine—Nausea—Losartan—coronary artery disease	3.66e-05	0.000277	CcSEcCtD
Cyclobenzaprine—Pruritus—Timolol—coronary artery disease	3.65e-05	0.000276	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Ramipril—coronary artery disease	3.61e-05	0.000273	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Timolol—coronary artery disease	3.53e-05	0.000267	CcSEcCtD
Cyclobenzaprine—Trimipramine—CYP2C19—coronary artery disease	3.53e-05	0.0116	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Lisinopril—coronary artery disease	3.53e-05	0.000267	CcSEcCtD
Cyclobenzaprine—Dizziness—Ramipril—coronary artery disease	3.49e-05	0.000264	CcSEcCtD
Cyclobenzaprine—Diphenhydramine—CYP2C19—coronary artery disease	3.47e-05	0.0114	CrCbGaD
Cyclobenzaprine—Asthenia—Lisinopril—coronary artery disease	3.44e-05	0.00026	CcSEcCtD
Cyclobenzaprine—Dizziness—Timolol—coronary artery disease	3.41e-05	0.000258	CcSEcCtD
Cyclobenzaprine—Pruritus—Lisinopril—coronary artery disease	3.39e-05	0.000256	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP2C19—coronary artery disease	3.37e-05	0.0111	CrCbGaD
Cyclobenzaprine—Doxepin—CYP2C19—coronary artery disease	3.36e-05	0.0111	CrCbGaD
Cyclobenzaprine—Vomiting—Ramipril—coronary artery disease	3.36e-05	0.000254	CcSEcCtD
Cyclobenzaprine—Rash—Ramipril—coronary artery disease	3.33e-05	0.000252	CcSEcCtD
Cyclobenzaprine—Dermatitis—Ramipril—coronary artery disease	3.33e-05	0.000251	CcSEcCtD
Cyclobenzaprine—Headache—Ramipril—coronary artery disease	3.31e-05	0.00025	CcSEcCtD
Cyclobenzaprine—Vomiting—Timolol—coronary artery disease	3.28e-05	0.000248	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Lisinopril—coronary artery disease	3.28e-05	0.000248	CcSEcCtD
Cyclobenzaprine—Rash—Timolol—coronary artery disease	3.26e-05	0.000246	CcSEcCtD
Cyclobenzaprine—Dermatitis—Timolol—coronary artery disease	3.25e-05	0.000246	CcSEcCtD
Cyclobenzaprine—Headache—Timolol—coronary artery disease	3.23e-05	0.000244	CcSEcCtD
Cyclobenzaprine—Dizziness—Lisinopril—coronary artery disease	3.17e-05	0.000239	CcSEcCtD
Cyclobenzaprine—Nausea—Ramipril—coronary artery disease	3.14e-05	0.000237	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—HTR2A—coronary artery disease	3.1e-05	0.0102	CrCbGaD
Cyclobenzaprine—Nausea—Timolol—coronary artery disease	3.07e-05	0.000232	CcSEcCtD
Cyclobenzaprine—Vomiting—Lisinopril—coronary artery disease	3.05e-05	0.00023	CcSEcCtD
Cyclobenzaprine—Nortriptyline—HTR2A—coronary artery disease	3.04e-05	0.01	CrCbGaD
Cyclobenzaprine—Rash—Lisinopril—coronary artery disease	3.02e-05	0.000228	CcSEcCtD
Cyclobenzaprine—Dermatitis—Lisinopril—coronary artery disease	3.02e-05	0.000228	CcSEcCtD
Cyclobenzaprine—Headache—Lisinopril—coronary artery disease	3e-05	0.000227	CcSEcCtD
Cyclobenzaprine—Promazine—CYP2C19—coronary artery disease	2.99e-05	0.00984	CrCbGaD
Cyclobenzaprine—Trimipramine—HTR2A—coronary artery disease	2.86e-05	0.00941	CrCbGaD
Cyclobenzaprine—Nausea—Lisinopril—coronary artery disease	2.84e-05	0.000215	CcSEcCtD
Cyclobenzaprine—Promethazine—HTR2A—coronary artery disease	2.75e-05	0.00906	CrCbGaD
Cyclobenzaprine—Doxepin—HTR2A—coronary artery disease	2.73e-05	0.00897	CrCbGaD
Cyclobenzaprine—Imipramine—CYP2C19—coronary artery disease	2.62e-05	0.00861	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP2C19—coronary artery disease	2.6e-05	0.00856	CrCbGaD
Cyclobenzaprine—Promazine—HTR2A—coronary artery disease	2.42e-05	0.00797	CrCbGaD
Cyclobenzaprine—Imipramine—HTR2A—coronary artery disease	2.12e-05	0.00698	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR2A—coronary artery disease	2.11e-05	0.00694	CrCbGaD
Cyclobenzaprine—Nortriptyline—ALB—coronary artery disease	2.08e-05	0.00684	CrCbGaD
Cyclobenzaprine—Amitriptyline—ALB—coronary artery disease	1.44e-05	0.00475	CrCbGaD
Cyclobenzaprine—CYP2D6—Metabolism—VCAN—coronary artery disease	5.39e-06	0.000186	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HADHA—coronary artery disease	5.37e-06	0.000185	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDOA—coronary artery disease	5.35e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.35e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HK2—coronary artery disease	5.35e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTA1—coronary artery disease	5.31e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LPA—coronary artery disease	5.25e-06	0.000181	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ITGAV—coronary artery disease	5.2e-06	0.000179	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—DCN—coronary artery disease	5.19e-06	0.000179	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KNG1—coronary artery disease	5.18e-06	0.000179	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—POMC—coronary artery disease	5.17e-06	0.000178	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CREB1—coronary artery disease	5.17e-06	0.000178	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AGTR1—coronary artery disease	5.15e-06	0.000178	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.13e-06	0.000177	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLCB3—coronary artery disease	5.09e-06	0.000175	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCL2—coronary artery disease	5.05e-06	0.000174	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDH2—coronary artery disease	5.05e-06	0.000174	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6R—coronary artery disease	5.04e-06	0.000174	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL10—coronary artery disease	5.04e-06	0.000174	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOA5—coronary artery disease	5.03e-06	0.000174	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CPT1B—coronary artery disease	5.03e-06	0.000173	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LCAT—coronary artery disease	5.03e-06	0.000173	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PLG—coronary artery disease	5.02e-06	0.000173	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—P4HB—coronary artery disease	4.94e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA4—coronary artery disease	4.93e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HBA1—coronary artery disease	4.92e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	4.92e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LIPC—coronary artery disease	4.92e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	4.92e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOC3—coronary artery disease	4.89e-06	0.000169	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.89e-06	0.000169	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRB2—coronary artery disease	4.89e-06	0.000169	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LDLR—coronary artery disease	4.86e-06	0.000168	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	4.85e-06	0.000167	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKCE—coronary artery disease	4.83e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—JAK2—coronary artery disease	4.82e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SOCS1—coronary artery disease	4.81e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTT1—coronary artery disease	4.81e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	4.81e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—S100B—coronary artery disease	4.8e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	4.79e-06	0.000165	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.77e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GCLM—coronary artery disease	4.77e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SOCS3—coronary artery disease	4.75e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GCLC—coronary artery disease	4.75e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CETP—coronary artery disease	4.75e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.74e-06	0.000163	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TGFBR2—coronary artery disease	4.7e-06	0.000162	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KITLG—coronary artery disease	4.7e-06	0.000162	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SDC1—coronary artery disease	4.7e-06	0.000162	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.62e-06	0.000159	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.62e-06	0.000159	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—STAT5A—coronary artery disease	4.59e-06	0.000158	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP3—coronary artery disease	4.59e-06	0.000158	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—VCAN—coronary artery disease	4.57e-06	0.000157	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.55e-06	0.000157	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDOA—coronary artery disease	4.53e-06	0.000156	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HADH—coronary artery disease	4.48e-06	0.000154	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.48e-06	0.000154	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOB—coronary artery disease	4.44e-06	0.000153	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PSMB5—coronary artery disease	4.44e-06	0.000153	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PSMA6—coronary artery disease	4.44e-06	0.000153	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCL8—coronary artery disease	4.4e-06	0.000152	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—DCN—coronary artery disease	4.4e-06	0.000152	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—JAK2—coronary artery disease	4.38e-06	0.000151	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDN1—coronary artery disease	4.37e-06	0.000151	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CTGF—coronary artery disease	4.33e-06	0.000149	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL5—coronary artery disease	4.33e-06	0.000149	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GOT2—coronary artery disease	4.3e-06	0.000148	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMGCR—coronary artery disease	4.3e-06	0.000148	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDH2—coronary artery disease	4.28e-06	0.000148	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGF1—coronary artery disease	4.27e-06	0.000147	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CSF2—coronary artery disease	4.27e-06	0.000147	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.25e-06	0.000146	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GPX2—coronary artery disease	4.25e-06	0.000146	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA2—coronary artery disease	4.25e-06	0.000146	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LPL—coronary artery disease	4.24e-06	0.000146	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RPS6KB1—coronary artery disease	4.2e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MEF2C—coronary artery disease	4.2e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.2e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GPX4—coronary artery disease	4.2e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.2e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HK1—coronary artery disease	4.2e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.17e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	4.17e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2C19—coronary artery disease	4.17e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HBA1—coronary artery disease	4.17e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LIPC—coronary artery disease	4.17e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HADHA—coronary artery disease	4.15e-06	0.000143	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOC3—coronary artery disease	4.15e-06	0.000143	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LDLR—coronary artery disease	4.12e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.12e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.1e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ITGB3—coronary artery disease	4.09e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTT1—coronary artery disease	4.07e-06	0.00014	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC9A1—coronary artery disease	4.07e-06	0.00014	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LPA—coronary artery disease	4.05e-06	0.00014	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CETP—coronary artery disease	4.02e-06	0.000139	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GCLC—coronary artery disease	4.02e-06	0.000139	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCL8—coronary artery disease	4e-06	0.000138	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SDC1—coronary artery disease	3.98e-06	0.000137	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PPP2CA—coronary artery disease	3.98e-06	0.000137	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.95e-06	0.000136	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.92e-06	0.000135	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKCD—coronary artery disease	3.9e-06	0.000135	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA5—coronary artery disease	3.89e-06	0.000134	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.83e-06	0.000132	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—C3—coronary artery disease	3.82e-06	0.000132	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—P4HB—coronary artery disease	3.81e-06	0.000131	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PSMA6—coronary artery disease	3.76e-06	0.00013	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PSMB5—coronary artery disease	3.76e-06	0.00013	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.75e-06	0.000129	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.74e-06	0.000129	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GGT1—coronary artery disease	3.71e-06	0.000128	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GOT1—coronary artery disease	3.71e-06	0.000128	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CTGF—coronary artery disease	3.67e-06	0.000127	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMGCR—coronary artery disease	3.64e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GOT2—coronary artery disease	3.64e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HIF1A—coronary artery disease	3.64e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AGT—coronary artery disease	3.63e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOE—coronary artery disease	3.55e-06	0.000122	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LEP—coronary artery disease	3.55e-06	0.000122	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—VCAN—coronary artery disease	3.53e-06	0.000122	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOA1—coronary artery disease	3.51e-06	0.000121	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.5e-06	0.000121	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KDR—coronary artery disease	3.48e-06	0.00012	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	3.46e-06	0.000119	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—DCN—coronary artery disease	3.4e-06	0.000117	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ESR1—coronary artery disease	3.39e-06	0.000117	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FN1—coronary artery disease	3.35e-06	0.000115	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—F2—coronary artery disease	3.35e-06	0.000115	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLCB1—coronary artery disease	3.35e-06	0.000115	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	3.34e-06	0.000115	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.33e-06	0.000115	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	3.31e-06	0.000114	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.3e-06	0.000114	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.3e-06	0.000114	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.29e-06	0.000113	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.28e-06	0.000113	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCA1—coronary artery disease	3.24e-06	0.000112	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CAT—coronary artery disease	3.24e-06	0.000112	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LIPC—coronary artery disease	3.22e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HBA1—coronary artery disease	3.22e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.22e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.22e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KIT—coronary artery disease	3.21e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOC3—coronary artery disease	3.2e-06	0.00011	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LDLR—coronary artery disease	3.18e-06	0.00011	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOB—coronary artery disease	3.15e-06	0.000108	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.14e-06	0.000108	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.14e-06	0.000108	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GGT1—coronary artery disease	3.14e-06	0.000108	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GOT1—coronary artery disease	3.14e-06	0.000108	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GCLC—coronary artery disease	3.11e-06	0.000107	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CETP—coronary artery disease	3.11e-06	0.000107	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	3.08e-06	0.000106	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SDC1—coronary artery disease	3.07e-06	0.000106	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.06e-06	0.000106	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—POMC—coronary artery disease	3.05e-06	0.000105	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CREB1—coronary artery disease	3.05e-06	0.000105	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LPL—coronary artery disease	3e-06	0.000104	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL2—coronary artery disease	2.99e-06	0.000103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6R—coronary artery disease	2.98e-06	0.000103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1—coronary artery disease	2.94e-06	0.000101	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GPX1—coronary artery disease	2.93e-06	0.000101	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	2.92e-06	0.000101	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.9e-06	0.0001	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.9e-06	0.0001	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CD36—coronary artery disease	2.85e-06	9.84e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CTGF—coronary artery disease	2.83e-06	9.77e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.82e-06	9.73e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.82e-06	9.72e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.81e-06	9.68e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GOT2—coronary artery disease	2.81e-06	9.68e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.8e-06	9.64e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.79e-06	9.62e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	2.79e-06	9.61e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.78e-06	9.59e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CAT—coronary artery disease	2.75e-06	9.47e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.71e-06	9.33e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	2.7e-06	9.3e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOB—coronary artery disease	2.67e-06	9.19e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	2.66e-06	9.17e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.59e-06	8.94e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	2.59e-06	8.92e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.58e-06	8.9e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AGT—coronary artery disease	2.57e-06	8.86e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LPL—coronary artery disease	2.55e-06	8.78e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.54e-06	8.74e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOE—coronary artery disease	2.52e-06	8.68e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.5e-06	8.63e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOA1—coronary artery disease	2.49e-06	8.58e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GPX1—coronary artery disease	2.48e-06	8.56e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GGT1—coronary artery disease	2.42e-06	8.36e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GOT1—coronary artery disease	2.42e-06	8.36e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CD36—coronary artery disease	2.42e-06	8.34e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.39e-06	8.23e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	2.36e-06	8.14e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.29e-06	7.9e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	2.28e-06	7.86e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	2.26e-06	7.79e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	2.24e-06	7.74e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	2.2e-06	7.58e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARG—coronary artery disease	2.19e-06	7.56e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.18e-06	7.51e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AGT—coronary artery disease	2.18e-06	7.51e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—POMC—coronary artery disease	2.16e-06	7.46e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.16e-06	7.44e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.15e-06	7.4e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	2.14e-06	7.36e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOE—coronary artery disease	2.13e-06	7.36e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CAT—coronary artery disease	2.12e-06	7.31e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOA1—coronary artery disease	2.11e-06	7.27e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	2.07e-06	7.14e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOB—coronary artery disease	2.06e-06	7.09e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.02e-06	6.96e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2e-06	6.9e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALB—coronary artery disease	1.97e-06	6.8e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LPL—coronary artery disease	1.96e-06	6.77e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.92e-06	6.61e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GPX1—coronary artery disease	1.92e-06	6.61e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NOS3—coronary artery disease	1.89e-06	6.5e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CD36—coronary artery disease	1.87e-06	6.43e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARG—coronary artery disease	1.86e-06	6.41e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.84e-06	6.35e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—POMC—coronary artery disease	1.83e-06	6.32e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.77e-06	6.1e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.76e-06	6.07e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.73e-06	5.95e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.73e-06	5.95e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AGT—coronary artery disease	1.68e-06	5.79e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALB—coronary artery disease	1.67e-06	5.76e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOE—coronary artery disease	1.65e-06	5.68e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA1—coronary artery disease	1.63e-06	5.61e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NOS3—coronary artery disease	1.6e-06	5.51e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	1.5e-06	5.16e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.46e-06	5.04e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.43e-06	4.94e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—POMC—coronary artery disease	1.41e-06	4.88e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—coronary artery disease	1.33e-06	4.57e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALB—coronary artery disease	1.29e-06	4.45e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.23e-06	4.25e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	1.22e-06	4.22e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.13e-06	3.89e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.06e-06	3.66e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	8.99e-07	3.1e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKT1—coronary artery disease	8.67e-07	2.99e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKT1—coronary artery disease	7.35e-07	2.53e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.94e-07	2.39e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKT1—coronary artery disease	5.67e-07	1.95e-05	CbGpPWpGaD
